Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome
Open Access
- 30 May 1996
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (22) , 1417-1422
- https://doi.org/10.1056/nejm199605303342201
Abstract
Patients with acute respiratory distress syndrome (ARDS) have a deficiency of surfactant. Surfactant replacement improves physiologic function in such patients, and preliminary data suggest that it may improve survival.Keywords
This publication has 27 references indexed in Scilit:
- Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993Published by American Medical Association (AMA) ,1995
- Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndromePublished by American Medical Association (AMA) ,1994
- Attitudes of critical care medicine professionals concerning forgoing life-sustaining treatmentCritical Care Medicine, 1992
- Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome.Journal of Clinical Investigation, 1991
- Sepsis syndromeCritical Care Medicine, 1989
- Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambsThe Journal of Pediatrics, 1985
- Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.Journal of Clinical Investigation, 1982
- Abnormalities in Lung Elastic Properties and Surfactant Function in Adult Respiratory Distress SyndromeChest, 1979
- ACUTE RESPIRATORY DISTRESS IN ADULTSThe Lancet, 1967
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958